| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 16:54 | Akebia Therapeutics announces corporate updates and 2026 pipeline outlook | ||
| 16:54 | HUB Cyber Security appoints Limor Zur-Stoller as CFO | ||
| 16:48 | AmpliTech receives $9M from $4 unit subscription rights offering | ||
| 16:48 | UBS opposes Swiss proposal to tighten banking rules after Credit Suisse collapse - report | ||
| 16:48 | Lulu's Fashion Lounge surges 45% after Friedland Enterprises takes 5% stake, pushes governance reforms | ||
| 16:48 | Petco seeks to refinance $1.5B debt, reaffirms guidance | ||
| 16:42 | The best large cap energy stocks by EPS revisions | ||
| 16:42 | Datadog, Appian both receive upgrades to Overweight by Morgan Stanley | ||
| 16:42 | HealthEquity expects FY 2027 revenue between $1.38B and $1.41B; shares down over 7% | ||
| 16:36 | Apple chooses Google's Gemini to run next version of Siri: report | ||
| 16:36 | Vince Holding holiday sales increase 5.3% | ||
| 16:36 | Eli Lilly, Nvidia to launch AI co-innovation lab for drug discovery | ||
| 16:24 | Maersk weighs using more ethanol use for its ships to cut reliance on China - FT | ||
| 16:24 | Descartes gets an upgrade, while Snowflake, DoubleVerify and GitLab cut at Barclays | ||
| 16:24 | Financial stocks with weakest earnings momentum heading into reporting season | ||
| 16:24 | Canadian National Railway plays defense against the Union Pacific-Norfolk Southern merger plan | ||
| 16:24 | FEI-Zyfer secures contracts totaling about $6M | ||
| 16:18 | Crypto startup BitGo files to raise up to $201M in IPO | ||
| 16:18 | Financial stocks with strongest earnings momentum heading into reporting season | ||
| 16:18 | Stoke down as FDA rebuffs expedited review of zorevunersen for Dravet syndrome | ||
| 16:18 | MDxHealth sees Q4 net sales of up to $30.5M and FY25 net sales of $109M | ||
| 16:12 | Amkor Technology downgraded at UBS on more balanced risk-reward | ||
| 16:12 | China quotas deepen Brazil's beef production slowdown | ||
| 16:00 | Wall Street moves lower amid Powell investigation | ||
| 15:54 | Beam Therapeutics shares jump on progress in precision genetic medicines and 2026 strategic plans |